SCOPUS 정보 검색 플랫폼

Cancer

Volumn 89, Issue 4, 2000, Pages 750-756

Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma

(5) Yang, Tai Shen a Lin, Yung Chang a Chen, Jen Shi a Wang, Hung Ming a Wang, Chen Hsu a

a CHANG GUNG MEMORIAL HOSPITAL (Taiwan)

Author keywords

Chemotherapy; Gemcitabine; Hepatocellular carcinoma; Multidrug resistance

Indexed keywords

ALPHA FETOPROTEIN; GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER TOXICITY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; DEOXYCYTIDINE; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034663193 PISSN: 0008543X EISSN: None Source Type: Journal
DOI: 10.1002/1097-0142(20000815)89:4<750::AID-CNCR5>3.0.CO;2-R Document Type: Article

Times cited : (138)

References (22)

1
- 0002247314
- Hepatocellular carcinoma in the world: Epidemiologic questions in etiology, pathology, and treatment of hepatocellular carcinoma in North America
- Tabor E, DiBisecglie AM, Purcell RH, editors: Advances in the Applied Biotechnology Series
- (1991) , pp. 35-54
- Bosch, F.X.¹ Munoz, N.²

2
- 0002656482
- Hepatobiliary system
- Devita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, ed 4. Philadelphia: J.B. Lippincott
- (1993) , pp. 883-914
- Lotze, M.T.¹ Flickinger, J.C.² Carr, B.J.³

3
- 0008163334
- R.O.C. Department of Health. Cancer registry annual report, Republic of China, 1995. Taipei, Taiwan: Department of Health, Executive Yuan
- (1998) , pp. 2-3

4
- 0028332826
- Treatment of hepatocellular carcinoma: Too many options?
- (1994) J Clin Oncol , vol.12 , pp. 1232-1234
- Venook, A.P.¹

5
- 0023936352
- Clinical trials in primary hepatocellular carcinoma: Current status and future directions
- (1988) Cancer Treat Rev , vol.15 , pp. 1-31
- Nerenstone, S.R.¹ Ihde, D.C.² Friedman, M.A.³

6
- 0000868374
- Antitumor activity of 2',2'-difluorodeoxycytidine (LY 188011)
- (1986) Proc Am Assoc Cancer Res , vol.27 , pp. 296-301
- Gridney, G.B.¹ Boder, G.B.² Hertel, L.W.³

7
- 0027263596
- The influence of the schedule and the dose of dFdc on the anti-tumor efficacy in experimental human cancer
- (1993) Br J Cancer , vol.68 , pp. 52-56
- Boven, E.¹ Schipper, H.² Erkelens, C.A.M.³ Hatty, S.A.⁴ Pinedo, H.M.⁵

8
- 0025978216
- A phase I clinical plasma and cellular pharmacology study of gemcitabine
- (1991) J Clin Oncol , vol.9 , pp. 491-498
- Abbruzzesse, J.L.¹ Grunewald, R.² Weeks, E.A.³ Gravel, D.⁴ Adams, T.⁵ Nowak, B.⁶

9
- 0342868637
- Weekly gemcitabine: A phase I study with short and prolonged infusion schedules
- (1992) Proc Am Soc Clin Oncol , vol.11 , pp. 329
- Pollera, C.F.¹ Ceribelli, A.² Crecco, M.³ Sabino, F.⁴ Calabresi, F.⁵

10
- 0032031603
- Antitumor effect of the nucleoside analogs 2-chlorodexyadesine and 2'2'-difluorodexycytidine on human hepatoma HepG2 cells
- (1998) J Hepatol , vol.28 , pp. 504-509
- Graziadei, I.¹ Kelly, T.² Schirmer, M.³ Geisen, F.H.⁴ Vogel, W.⁵ Konwalinka, G.⁶

11
- 0019365237
- Reporting results of cancer treatment
- (1981) Cancer , vol.47 , pp. 207-214
- Miller, A.B.¹ Hoogstraten, B.² Ataquet, M.³

12
- 0024536437
- Optimal two-stage designs for phase II clinical trials
- (1989) Control Clin Trials , vol.10 , pp. 1-10
- Simon, R.¹

13
- 33845382806
- Nonparametric estimation from incomplete observations
- (1959) J Am Stat Assoc , vol.53 , pp. 457-481
- Kaplan, E.M.¹ Meier, P.²

14
- 0025013836
- Doxorubicin for unresectable hepatocellular carcinoma
- (1990) Cancer , vol.66 , pp. 1685-1687
- Lai, E.C.S.¹ Choi, T.K.² Cheng, C.H.³ Mok, F.P.T.⁴ Fan, S.T.⁵ Tan, E.S.Y.⁶

15
- 0023765990
- Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma
- (1988) Cancer , vol.62 , pp. 479-483
- Lai, C.L.¹ Wu, P.C.² Chan, G.C.B.³ Lok, A.S.F.⁴ Lin, H.J.⁵

16
- 7144257852
- Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma
- (1998) Br J Cancer , vol.78 , Issue.1 , pp. 34-39
- Chao, Y.¹ Chan, W.K.² Birkhofer, M.J.³ Hu, O.P.Y.⁴ Wang, S.S.⁵ Huang, Y.S.⁶

17
- 0008202421
- A phase II trial of irinotecan (CPT-11) in patients with advanced hepatocellular carcinoma
- (1998) Proc Am Soc Clin Oncol , vol.267 , pp. 1026
- O'Reilly, E.¹ Stuart, K.² Kemeny, N.³ Steger, C.⁴ Raeburn, L.⁵ Sanz-Altamira, P.⁶

18
- 0030805676
- A phase II study of raltitrexed (Tomudex) in patients with hepatocellular carcinoma
- (1997) Ann Oncol , vol.8 , pp. 500-502
- Rougier, P.¹ Ducreux, M.² Kerr, D.³ Carr, B.I.⁴ Francois, E.⁵ Adenis, A.⁶

19
- 0033179412
- A phase II trial of nolatrexed dihydrochloride in patients with advanced hepatocellular carcinoma
- (1999) Cancer , vol.86 , pp. 410-414
- Stuart, K.¹ Tessitore, J.² Rudy, J.³ Clendennin, N.⁴ Johnston, A.⁵

20
- 0028069259
- Immunohistochemical study of expression and cellular localization of the multidrug resistance gene product P-glycoprotein in primary liver carcinoma
- (1994) Cancer , vol.73 , pp. 298-303
- Itsubo, M.¹ Ishikawa, T.² Toda, G.³ Tanaka, M.⁴

21
- 0027171458
- MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis
- (1993) J Hepatol , vol.18 , pp. 168-172
- Chenivesse, X.¹ Franco, D.² Brechot, C.³

22
- 0028334832
- MDR1 gene expression: Its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines
- (1994) J Natl Cancer Inst , vol.86 , pp. 700-705
- Park, J.G.¹ Lee, S.K.² Hong, I.G.³ Kim, H.S.⁴ Lim, K.H.⁵ Choe, K.J.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.